Clinical Trials Logo

Ulcerative Colitis clinical trials

View clinical trials related to Ulcerative Colitis.

Filter by:

NCT ID: NCT03059849 Not yet recruiting - Ulcerative Colitis Clinical Trials

Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD

BEAT-IBD
Start date: May 1, 2017
Phase: Phase 4
Study type: Interventional

To examine whether a temporary three month increase in adalimumab dosing will prevent relapse in patients with inflammatory bowel disease in clinical remission who have elevated calprotectin.

NCT ID: NCT03053713 Recruiting - Ulcerative Colitis Clinical Trials

The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

The Mediterranean Diet Pattern (MDP) has been shown to have beneficial effects on the intestinal bacteria and the immune system in diseases like cancer and diabetes. The aim of this study is to determine if a MDP will have an impact on symptoms, intestinal bacteria and the immune system in Ulcerative Colitis (UC). Symptoms, blood and stool will be examined to determine if the MDP results in changes to the intestinal bacteria or immune system.

NCT ID: NCT03051204 Not yet recruiting - Healthy Clinical Trials

OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome

OptiCal
Start date: March 2017
Phase: N/A
Study type: Observational

Study Aims: To analyze stool specimens to test and validate the CalproLab assay against the predicate PhiCal in order to determine performance characteristics. And to correlate Calpro levels to the gut microbiome composition.

NCT ID: NCT03038711 Recruiting - Ulcerative Colitis Clinical Trials

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers

Start date: February 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to understand if multiple oral doses of BMS-986166 are safe and well tolerated in healthy patients.

NCT ID: NCT03018925 Recruiting - Ulcerative Colitis Clinical Trials

Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis

GOLI2015
Start date: October 2016
Phase: N/A
Study type: Observational

This study aims to characterize the changes on intestinal microbiota pattern associated with the use of golimumab in order to determine if intestinal microbiota markers may correlate with golimumab therapeutic effect in patients naïve & non-naïve to anti-TNF treatment

NCT ID: NCT03016780 Recruiting - Ulcerative Colitis Clinical Trials

Fecal Microbiota Transplantation for Ulcerative Colitis

FMTFUC
Start date: July 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Ulcerative colitis is a common digestive system disease, the incidence is increasing in recent years.It is reported that the occurrence and development of ulcerative colitis is closely related to imbalance of intestinal flora .Moreover,intestinal mucosal immunity may be related to intestinal flora. Fecal microbiota transplantation as a new technology to rebuild intestinal flora has been used for several diseaseļ¼Œbut the efficacy of ulcerative colitis by fecal microbiota transplantation needs to be further explored.

NCT ID: NCT03011593 Completed - Ulcerative Colitis Clinical Trials

Effect of UGIR in Adults With Compromised Gut Function and Malabsorption

Start date: November 2015
Phase: N/A
Study type: Interventional

This study assessed the effect of a nutrition support product on quality of life in adults with compromised gut function and malabsorption.

NCT ID: NCT03006809 Not yet recruiting - Ulcerative Colitis Clinical Trials

Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis

Start date: February 2017
Phase: Phase 1
Study type: Interventional

This is a prospective unblinded, randomized trial for the use of Fecal Microbiota Transplantation (FMT) for the treatment of Ulcerative Colitis (UC), in combination with or without antibiotic pretreatment.

NCT ID: NCT03000101 Recruiting - Crohn's Disease Clinical Trials

Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Diseases

POME2016
Start date: December 2016
Phase: Phase 1
Study type: Interventional

The aim of this research is to study the effects of a pomegranate juice on calprotectin levels in patients suffering of inflammatory bowel diseases (IBD) in clinical remission. Fecal calprotectin levels, surrogate marker of mucosal inflammation, will be measured from baseline to 12 weeks later (end of intervention). Systemic and mucosal changes of biochemical and molecular inflammatory response markers will be also assessed.

NCT ID: NCT02998112 Recruiting - Ulcerative Colitis Clinical Trials

Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing

Start date: December 2016
Phase: Phase 4
Study type: Interventional

To indicate the efficacy of Fecal microbiota transplantation (FMT) for the treatment of Ulcerative colitis (UC), The investigators design a multicenter, randomized controlled trial to perform FMT through colonic transendoscopic enteral tubing (TET) way, and evaluate the efficacy and safety of FMT for patients with moderate or severe UC.